Key Industry Expert Speakers
Biosimilars & Biologics Global Congress 2024 Europe
5th - 6th December 2024, London, United Kingdom
- Cecil Nick, Vice President (Technical), PAREXEL
- Peter Jørgensen, CEO, The Danish Generic and Biosimilar Medicines Association
- Dr. Steinar Madsen, Medical Director, Norwegian Medicines Agency
- Nick Stephens, Executive Chair, The RSA Group
- Jo Pisani, Board Member, Non-executive Director, The RSA Group
- Roman Irsiegler, Global Biosimilars Team Lead, Pfizer Global
- Mark Samuels, Chief Executive, British Biosimilars Association
- Senior Representative, Biocon
- Ashok Mishra, Head of Downstream - R&D (BIOTECH), Lupin Limited
- Rene Anour, Sr. Clinical Expert, Head of National Scientific Advice, AGES
- Nico Bacharidis, Member of the Board of Directors, Cube RM
- Justin Stebbing, Professor, Cancer Medicine & Oncology, Imperial College London
- Burkhard Pieper, Global Scientific Officer, Biogen Biosimilars Unit (BBU)
- H. Fai Poon, President, QuaCell Biotechnology, Co., Ltd.
- Hoori Kaskanian, Global Head Biopharmaceuticals Strategy, Sandoz
- Kristian Juergensen, Chief Commercial Officer, The RSA Group
- Poppy Moore, Senior Consultant, The RSA Group
- Sandy Chadwick, Head of Global Marketing, The RSA Group
- Rajpreet Grewal, Senior Medical Scientific Liaison, Fresenius-Kabi
- Zafer Toksöz, President & Founder, Arven Pharmaceuticals
- Caroline Boulliat, CEO & Founder, Genchrome Limited
- Rodeina Challand B.Sc., LLB., VP Scientific Affairs, BioFactura, Inc.